TABLE 3.
Altered Gene Expression in AhR−/− BMM in Response to Inflammasome Activation Revealed by Real time-PCR
Pro-IL-1β |
IL-6 |
STAT2 |
STAT5a |
Pai-2 |
Bcl-2 |
|||||||
Silica + LPS | Silica + LPS + caspase-1 inhibitor | Silica + LPS | Silica + LPS + caspase-1 inhibitor | Silica + LPS | Silica + LPS + caspase-1 inhibitor | Silica + LPS | Silica + LPS + caspase-1 inhibitor | Silica + LPS | Silica + LPS + caspase-1 inhibitor | Silica + LPS | Silica + LPS + caspase-1 inhibitor | |
C57Bl/6 | 2179.83 | 413.00 | 31.78 | 30.91 | 8.69 | 2.22 | 0.95 | 0.90 | 643.59 | 652.58 | 0.20 | 0.55 |
AhR−/− | 3258.52 | 1606.83 | 138.14 | 248.99 | 4.53 | 1.20 | 0.53 | 0.56 | 20.97 | 43.41 | 0.53 | 1.25 |
Note. Bone marrow macrophages derived from AhR−/− mice show elevated mRNA levels of pro-IL-1β, IL-6, and Bcl-2, yet decreased mRNA levels of STAT2, STAT5a, and serpin B2 (Pai-2) compared with wild-type C57Bl/6 macrophages in response to Nlrp3 inflammasome activation. Inhibition of caspase-1 activity with 20μM Ac-Tyr-Val-Ala-Asp-CMK showed caspase-1–dependent induction of pro-IL-1β, STAT2, and BcL-2 in response to NLrp3 inflammasome activation. Values are expressed as fold change of ΔΔCT over respective untreated vehicle control, n = 3, pooled.